{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:26:01Z","timestamp":1790864761364,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T00:00:00Z","timestamp":1572652800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012479","name":"Weston Brain Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.nbd.2019.104668","type":"journal-article","created":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T20:03:42Z","timestamp":1572897822000},"page":"104668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["A peptide inhibitor of Tau-SH3 interactions ameliorates amyloid-\u03b2 toxicity"],"prefix":"10.1016","volume":"134","author":[{"given":"Travis","family":"Rush","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan R.","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha J.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam R.","family":"Aldaher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9852-5504","authenticated-orcid":false,"given":"J. Nicholas","family":"Cochran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik D.","family":"Roberson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.nbd.2019.104668_bb0005","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.chembiol.2014.09.001","article-title":"Small-molecule inhibitors of protein-protein interactions: progressing toward the reality","volume":"21","author":"Arkin","year":"2014","journal-title":"Chem. Biol."},{"issue":"42","key":"10.1016\/j.nbd.2019.104668_bb0010","doi-asserted-by":"crossref","first-page":"35119","DOI":"10.1074\/jbc.M505895200","article-title":"Disease-related modifications in tau affect the interaction between Fyn and tau","volume":"280","author":"Bhaskar","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.nbd.2019.104668_bb0015","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.celrep.2016.09.063","article-title":"Loss of Bin1 promotes the propagation of Tau pathology","volume":"17","author":"Calafate","year":"2016","journal-title":"Cell Rep."},{"issue":"11","key":"10.1016\/j.nbd.2019.104668_bb0020","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/mp.2013.1","article-title":"Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology","volume":"18","author":"Chapuis","year":"2013","journal-title":"Mol. Psychiatry"},{"issue":"19","key":"10.1016\/j.nbd.2019.104668_bb0025","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.1523\/JNEUROSCI.0277-04.2004","article-title":"Fyn kinase modulates synaptotoxicity, but not aberrant sprouting, in human amyloid precursor protein transgenic mice","volume":"24","author":"Chin","year":"2004","journal-title":"J. Neurosci."},{"issue":"42","key":"10.1016\/j.nbd.2019.104668_bb0030","doi-asserted-by":"crossref","first-page":"9694","DOI":"10.1523\/JNEUROSCI.2980-05.2005","article-title":"Fyn kinase induces synaptic and cognitive impairments in a transgenic mouse model of Alzheimer\u2019s disease","volume":"25","author":"Chin","year":"2005","journal-title":"J. Neurosci."},{"issue":"10","key":"10.1016\/j.nbd.2019.104668_bb0035","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1177\/1087057114547232","article-title":"AlphaScreen HTS and live-cell bioluminescence resonance energy transfer (BRET) assays for identification of tau-Fyn SH3 interaction inhibitors for Alzheimer disease","volume":"19","author":"Cochran","year":"2014","journal-title":"J. Biomol. Screen."},{"issue":"7","key":"10.1016\/j.nbd.2019.104668_bb0040","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","article-title":"Tau-targeting therapies for Alzheimer disease","volume":"14","author":"Congdon","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"3","key":"10.1016\/j.nbd.2019.104668_bb0045","doi-asserted-by":"crossref","first-page":"157","DOI":"10.14283\/jpad.2019.14","article-title":"Anti-tau trials for Alzheimer\u2019s disease: a report from the EU\/US\/CTAD task force","volume":"6","author":"Cummings","year":"2019","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2019.104668_bb0050","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1242\/jcs.114.6.1179","article-title":"Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice","volume":"114","author":"Dawson","year":"2001","journal-title":"J. Cell Sci."},{"issue":"31","key":"10.1016\/j.nbd.2019.104668_bb0055","doi-asserted-by":"crossref","first-page":"12887","DOI":"10.1523\/JNEUROSCI.2107-13.2013","article-title":"Antisense reduction of tau in adult mice protects against seizures","volume":"33","author":"Devos","year":"2013","journal-title":"J. Neurosci."},{"issue":"374","key":"10.1016\/j.nbd.2019.104668_bb0060","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag0481","article-title":"Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy","volume":"9","author":"DeVos","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"17","key":"10.1016\/j.nbd.2019.104668_bb0065","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1523\/JNEUROSCI.4261-13.2014","article-title":"Activity-dependent tau protein translocation to excitatory synapse is disrupted by exposure to amyloid-Beta oligomers","volume":"34","author":"Frandemiche","year":"2014","journal-title":"J. Neurosci."},{"issue":"10","key":"10.1016\/j.nbd.2019.104668_bb0070","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/WNR.0b013e32818b2a0b","article-title":"14-3-3 proteins and protein phosphatases are not reduced in tau-deficient mice","volume":"18","author":"Fujio","year":"2007","journal-title":"Neuroreport."},{"issue":"3","key":"10.1016\/j.nbd.2019.104668_bb0075","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/ana.24230","article-title":"Tau reduction prevents disease in a mouse model of Dravet syndrome","volume":"76","author":"Gheyara","year":"2014","journal-title":"Ann. Neurol."},{"issue":"11","key":"10.1016\/j.nbd.2019.104668_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007707","article-title":"Fyn mediates leptin actions in the thymus of rodents","volume":"4","author":"Girasol","year":"2009","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.nbd.2019.104668_bb0085","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00702-004-0221-0","article-title":"Post-translational modifications of tau protein in Alzheimer\u2019s disease","volume":"112","author":"Gong","year":"2005","journal-title":"J. Neural Transm."},{"issue":"13","key":"10.1016\/j.nbd.2019.104668_bb0090","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1016\/S0021-9258(17)38495-8","article-title":"Microtubule-associated protein tau. A component of Alzheimer paired helical filaments","volume":"261","author":"Grundke-Iqbal","year":"1986","journal-title":"J. Biol. Chem."},{"issue":"6480","key":"10.1016\/j.nbd.2019.104668_bb0095","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/369488a0","article-title":"Altered microtubule organization in small-calibre axons of mice lacking tau protein","volume":"369","author":"Harada","year":"1994","journal-title":"Nature."},{"issue":"4","key":"10.1016\/j.nbd.2019.104668_bb0100","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1523\/JNEUROSCI.3191-12.2013","article-title":"Tau loss attenuates neuronal network hyperexcitability in mouse and Drosophila genetic models of epilepsy","volume":"33","author":"Holth","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.104668_bb0105","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/31508","article-title":"Association of missense and 5\u2032-splice-site mutations in tau with the inherited dementia FTDP-17","volume":"393","author":"Hutton","year":"1998","journal-title":"Nature."},{"issue":"6","key":"10.1016\/j.nbd.2019.104668_bb0110","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1093\/oxfordjournals.jbchem.a135662","article-title":"Phosphorylated tau protein is integrated into paired helical filaments in Alzheimer\u2019s disease","volume":"99","author":"Ihara","year":"1986","journal-title":"J. Biochem."},{"issue":"3","key":"10.1016\/j.nbd.2019.104668_bb0115","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0304-3940(99)00964-7","article-title":"Muscle weakness, hyperactivity, and impairment in fear conditioning in tau-deficient mice","volume":"279","author":"Ikegami","year":"2000","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.nbd.2019.104668_bb0120","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuron.2018.06.003","article-title":"Dendritic tau in Alzheimer\u2019s disease","volume":"99","author":"Ittner","year":"2018","journal-title":"Neuron."},{"issue":"3","key":"10.1016\/j.nbd.2019.104668_bb0125","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","article-title":"Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer\u2019s disease mouse models","volume":"142","author":"Ittner","year":"2010","journal-title":"Cell."},{"issue":"6314","key":"10.1016\/j.nbd.2019.104668_bb0130","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1126\/science.aah6205","article-title":"Site-specific phosphorylation of tau inhibits amyloid-beta toxicity in Alzheimer\u2019s mice","volume":"354","author":"Ittner","year":"2016","journal-title":"Science."},{"issue":"11","key":"10.1016\/j.nbd.2019.104668_bb0135","article-title":"Alzheimer\u2019s therapeutics targeting amyloid beta 1\u201342 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits","volume":"9","author":"Izzo","year":"2014","journal-title":"PLoS One"},{"issue":"4\u20135","key":"10.1016\/j.nbd.2019.104668_bb0140","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000369995","article-title":"Fyn in neurodevelopment and ischemic brain injury","volume":"37","author":"Knox","year":"2015","journal-title":"Dev. Neurosci."},{"issue":"6","key":"10.1016\/j.nbd.2019.104668_bb0145","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1101\/lm.5.6.429","article-title":"Higher seizure susceptibility and enhanced tyrosine phosphorylation of N-methyl-D-aspartate receptor subunit 2B in fyn transgenic mice","volume":"5","author":"Kojima","year":"1998","journal-title":"Learn. Mem."},{"key":"10.1016\/j.nbd.2019.104668_bb0150","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","article-title":"Diffusible, nonfibrillar ligands derived from A\u03b21-42 are potent central nervous system neurotoxins","volume":"95","author":"Lambert","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.nbd.2019.104668_bb0155","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng.2802","article-title":"Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease","volume":"45","author":"Lambert","year":"2013","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.nbd.2019.104668_bb0160","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40478-016-0317-4","article-title":"Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer\u2019s disease","volume":"4","author":"Lau","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"issue":"2\u20133","key":"10.1016\/j.nbd.2019.104668_bb0165","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.bbadis.2004.09.002","article-title":"Tau and src family tyrosine kinases","volume":"1739","author":"Lee","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2019.104668_bb0170","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1242\/jcs.111.21.3167","article-title":"Tau interacts with src-family non-receptor tyrosine kinases","volume":"111","author":"Lee","year":"1998","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.nbd.2019.104668_bb0175","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1750-1326-9-29","article-title":"Motor and cognitive deficits in aged tau knockout mice in two background strains","volume":"9","author":"Lei","year":"2014","journal-title":"Mol. Neurodegener."},{"issue":"6","key":"10.1016\/j.nbd.2019.104668_bb0180","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.ajpath.2012.08.012","article-title":"Lack of tau proteins rescues neuronal cell death and decreases amyloidogenic processing of APP in APP\/PS1 mice","volume":"181","author":"Leroy","year":"2012","journal-title":"Am. J. Pathol."},{"issue":"21","key":"10.1016\/j.nbd.2019.104668_bb0185","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.15252\/embj.201797724","article-title":"Somatodendritic accumulation of Tau in Alzheimer\u2019s disease is promoted by Fyn-mediated local protein translation","volume":"36","author":"Li","year":"2017","journal-title":"EMBO J."},{"issue":"11","key":"10.1016\/j.nbd.2019.104668_bb0190","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1016\/j.neurobiolaging.2014.05.001","article-title":"Seizure resistance without parkinsonism in aged mice after tau reduction","volume":"35","author":"Li","year":"2014","journal-title":"Neurobiol. Aging"},{"issue":"6","key":"10.1016\/j.nbd.2019.104668_bb0195","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1046\/j.1471-4159.1997.69062285.x","article-title":"Cytotoxic amyloid peptides inhibit cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction by enhancing MTT formazan exocytosis","volume":"69","author":"Liu","year":"1997","journal-title":"J. Neurochem."},{"issue":"43","key":"10.1016\/j.nbd.2019.104668_bb0200","article-title":"The role of NMDA receptors in Alzheimer\u2019s disease","volume":"13","author":"Liu","year":"2019","journal-title":"Front. Neurosci."},{"issue":"19","key":"10.1016\/j.nbd.2019.104668_bb0205","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1523\/JNEUROSCI.0590-08.2008","article-title":"Enkephalin elevations contribute to neuronal and behavioral impairments in a transgenic mouse model of Alzheimer\u2019s disease","volume":"28","author":"Meilandt","year":"2008","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.nbd.2019.104668_bb0210","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13024-017-0176-x","article-title":"Phosphorylation of tau at Y18, but not tau-fyn binding, is required for tau to modulate NMDA receptor-dependent excitotoxicity in primary neuronal culture","volume":"12","author":"Miyamoto","year":"2017","journal-title":"Mol. Neurodegener."},{"issue":"38","key":"10.1016\/j.nbd.2019.104668_bb0215","doi-asserted-by":"crossref","first-page":"32040","DOI":"10.1074\/jbc.M112.401240","article-title":"Interaction of endogenous tau protein with synaptic proteins is regulated by N-methyl-D-aspartate receptor-dependent tau phosphorylation","volume":"287","author":"Mondrag\u00f3n-Rodr\u00edguez","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.nbd.2019.104668_bb0220","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.neurobiolaging.2012.12.003","article-title":"Age-appropriate cognition and subtle dopamine-independent motor deficits in aged Tau knockout mice","volume":"34","author":"Morris","year":"2013","journal-title":"Neurobiol. Aging"},{"issue":"7400","key":"10.1016\/j.nbd.2019.104668_bb0225","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nature11060","article-title":"Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-\u03b2","volume":"485","author":"Nussbaum","year":"2012","journal-title":"Nature."},{"issue":"4","key":"10.1016\/j.nbd.2019.104668_bb0230","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/archneurol.2009.15","article-title":"Epilepsy and cognitive impairments in Alzheimer disease","volume":"66","author":"Palop","year":"2009","journal-title":"Arch. Neurol."},{"issue":"5","key":"10.1016\/j.nbd.2019.104668_bb0235","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.neuron.2007.07.025","article-title":"Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer\u2019s disease","volume":"55","author":"Palop","year":"2007","journal-title":"Neuron."},{"key":"10.1016\/j.nbd.2019.104668_bb0240","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.neuron.2007.07.025","article-title":"Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer\u2019s disease","volume":"55","author":"Palop","year":"2007","journal-title":"Neuron."},{"issue":"21","key":"10.1016\/j.nbd.2019.104668_bb0245","doi-asserted-by":"crossref","first-page":"8169","DOI":"10.1523\/JNEUROSCI.17-21-08169.1997","article-title":"Inhibition of synaptic transmission by neuropeptide Y in rat hippocampal area CA1: modulation of presynaptic Ca2+ entry","volume":"17","author":"Qian","year":"1997","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.nbd.2019.104668_bb0250","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/humu.20086","article-title":"The role of tau (MAPT) in frontotemporal dementia and related tauopathies","volume":"24","author":"Rademakers","year":"2004","journal-title":"Hum. Mutat."},{"issue":"9","key":"10.1016\/j.nbd.2019.104668_bb0255","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1073\/pnas.092136199","article-title":"Tau is essential to \u03b2-amyloid-induced neurotoxicity","volume":"99","author":"Rapoport","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5825","key":"10.1016\/j.nbd.2019.104668_bb0260","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1126\/science.1141736","article-title":"Reducing endogenous tau ameliorates amyloid \u03b2-induced deficits in an Alzheimer\u2019s disease mouse model","volume":"316","author":"Roberson","year":"2007","journal-title":"Science."},{"issue":"2","key":"10.1016\/j.nbd.2019.104668_bb0265","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1523\/JNEUROSCI.4152-10.2011","article-title":"Amyloid-\u03b2\/Fyn\u2013induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer\u2019s disease","volume":"31","author":"Roberson","year":"2011","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.nbd.2019.104668_bb0270","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1523\/JNEUROSCI.1873-18.2018","article-title":"Alzheimer\u2019s disease risk factor Pyk2 mediates amyloid-beta-induced synaptic dysfunction and loss","volume":"39","author":"Salazar","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.104668_bb0275","series-title":"Acta Neuropathol","article-title":"BIN1 recovers tauopathy-induced long-term memory deficits in mice and interacts with Tau through Thr(348) phosphorylation","author":"Sartori","year":"2019"},{"key":"10.1016\/j.nbd.2019.104668_bb0280","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40478-015-0237-8","article-title":"Tau phosphorylation regulates the interaction between BIN1\u2019s SH3 domain and Tau\u2019s proline-rich domain","volume":"3","author":"Sottejeau","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"issue":"9","key":"10.1016\/j.nbd.2019.104668_bb0285","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1093\/brain\/aww187","article-title":"Hyperphosphorylated tau in patients with refractory epilepsy correlates with cognitive decline: a study of temporal lobe resections","volume":"139","author":"Tai","year":"2016","journal-title":"Brain."},{"issue":"1","key":"10.1016\/j.nbd.2019.104668_bb0290","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/82868","article-title":"Neurotrophins are required for nerve growth during development","volume":"4","author":"Tucker","year":"2001","journal-title":"Nat. Neurosci."},{"issue":"16","key":"10.1016\/j.nbd.2019.104668_bb0295","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1111\/j.1742-4658.2011.08218.x","article-title":"Tyrosine phosphorylation of tau regulates its interactions with Fyn SH2 domains, but not SH3 domains, altering the cellular localization of tau","volume":"278","author":"Usardi","year":"2011","journal-title":"FEBS J."},{"issue":"10","key":"10.1016\/j.nbd.2019.104668_bb0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163236","article-title":"No overt deficits in aged tau-deficient C57Bl\/6.Mapttm1(EGFP)kit GFP Knockin mice","volume":"11","author":"van Hummel","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.nbd.2019.104668_bb0305","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrn.2015.1","article-title":"Tau in physiology and pathology","volume":"17","author":"Wang","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"issue":"13","key":"10.1016\/j.nbd.2019.104668_bb0310","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1523\/JNEUROSCI.4749-06.2007","article-title":"Ethanol induces long-term facilitation of NR2B-NMDA receptor activity in the dorsal striatum: implications for alcohol drinking behavior","volume":"27","author":"Wang","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.104668_bb0315","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jmgm.2019.05.004","article-title":"Systematic profiling of SH3-mediated tau-partner interaction network in Alzheimer\u2019s disease by integrating in silico analysis and in vitro assay","volume":"90","author":"Wang","year":"2019","journal-title":"J. Mol. Graph. Model."},{"issue":"5","key":"10.1016\/j.nbd.2019.104668_bb0320","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1073\/pnas.72.5.1858","article-title":"A protein factor essential for microtubule assembly","volume":"72","author":"Weingarten","year":"1975","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996119303432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996119303432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:21:31Z","timestamp":1760851291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996119303432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":64,"alternative-id":["S0969996119303432"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2019.104668","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/825760","asserted-by":"object"}]},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A peptide inhibitor of Tau-SH3 interactions ameliorates amyloid-\u03b2 toxicity","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2019.104668","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104668"}}